Not Yet Recruiting PHASE2 INTERVENTIONAL 1-arm
NCT06838546
A Multicenter, Open Phase IIb Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Colorectal Cancer
Sponsor: Sir Run Run Shaw Hospital
Conditions
Advanced Colorectal Cancer
Interventions
B1962
Updated 1 time since 2025 Last updated: Feb 17, 2025 Started: Feb 24, 2025 Primary completion: Jan 1, 2027 Completion: Jan 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Advanced Colorectal Cancer, this trial is actively recruiting participants. The trial is conducted by Sir Run Run Shaw Hospital and has accumulated 1 data snapshot since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Sir Run Run Shaw Hospital
- Tasly Biopharmaceuticals Co., Ltd.
Data source: Tasly Biopharmaceuticals Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .